SaCas9
E1150943
UNEXPLORED
SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
All labels observed (1)
| Label | Occurrences |
|---|---|
| SaCas9 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T15313580 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SaCas9 Context triple: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
-
A.
Cpf1 (Cas12a)
Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
-
B.
CASP13
CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
-
C.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
-
D.
CASP14
CASP14 is the fourteenth edition of the Critical Assessment of protein Structure Prediction experiment, a community-wide benchmark for evaluating computational methods in protein structure modeling.
-
E.
CESAER
CESAER is a European association of leading universities of science and technology that collaborates to advance engineering education, research, and innovation.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SaCas9 Target entity description: SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
-
A.
Cpf1 (Cas12a)
Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
-
B.
CASP13
CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
-
C.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
-
D.
CASP14
CASP14 is the fourteenth edition of the Critical Assessment of protein Structure Prediction experiment, a community-wide benchmark for evaluating computational methods in protein structure modeling.
-
E.
CESAER
CESAER is a European association of leading universities of science and technology that collaborates to advance engineering education, research, and innovation.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.